Login
Home
Charts
Search
Watchlist
Products

Manipal Health Enterprises Ltd

MANIPALHOS·NSE
752.85+0.76%Tue, 22 Sept '26 10:15

Manipal Health Enterprises Ltd

MANIPALHOS
NSE
752.85
+0.76%
|Tue, 22 Sept '26 10:15
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
98,759Cr
Close
Close Price
750.80
Industry
Industry
Hospitals
PE
Price To Earnings
105.30
PS
Price To Sales
9.56
Revenue
Revenue
10,336Cr
Rev Gr TTM
Revenue Growth TTM
PAT Gr TTM
PAT Growth TTM

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterJun 2025Mar 2026Jun 2026
Revenue
RevenueCr
2,2382,8823,091
Growth YoY
Revenue Growth YoY%
38.1
Expenses
ExpensesCr
1,6512,1912,354
Operating Profit
Operating ProfitCr
586691737
OPM
OPM%
26.224.023.8
Other Income
Other IncomeCr
302759
Interest Expense
Interest ExpenseCr
132289293
Depreciation
DepreciationCr
141185187
PBT
PBTCr
344244315
Tax
TaxCr
905772
PAT
PATCr
254187243
Growth YoY
PAT Growth YoY%
-4.2
NPM
NPM%
11.36.57.9
EPS
EPS
2.21.52.0
QuarterJun 2025Mar 2026Jun 2026
Revenue
RevenueCr
2,2382,8823,091
Growth YoY
Revenue Growth YoY%
38.1
Expenses
ExpensesCr
1,6512,1912,354
Operating Profit
Operating ProfitCr
586691737
OPM
OPM%
26.224.023.8
Other Income
Other IncomeCr
302759
Interest Expense
Interest ExpenseCr
132289293
Depreciation
DepreciationCr
141185187
PBT
PBTCr
344244315
Tax
TaxCr
905772
PAT
PATCr
254187243
Growth YoY
PAT Growth YoY%
-4.2
NPM
NPM%
11.36.57.9
EPS
EPS
2.21.52.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
1,7622,1611,8133,9754,8066,1728,24210,336
Growth
Revenue Growth%
22.6-16.1119.220.928.433.525.4
Expenses
ExpensesCr
1,5001,7381,4833,0763,5624,4896,1167,725
Operating Profit
Operating ProfitCr
2624223309001,2441,6832,1272,611
OPM
OPM%
14.819.618.222.625.927.325.825.3
Other Income
Other IncomeCr
1694-28319-14-86134111
Interest Expense
Interest ExpenseCr
179222205326329455512864
Depreciation
DepreciationCr
209192183256315397507680
PBT
PBTCr
-111103-866375867451,2421,178
Tax
TaxCr
25463290157212161262
PAT
PATCr
-13656-1175474295331,082917
Growth
PAT Growth%
141.5-308.3565.9-21.524.3102.9-15.3
NPM
NPM%
-7.72.6-6.513.88.98.613.18.9
EPS
EPS
-19.68.1-20.073.557.45.39.37.7
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
1,7622,1611,8133,9754,8066,1728,24210,336
Growth
Revenue Growth%
22.6-16.1119.220.928.433.525.4
Expenses
ExpensesCr
1,5001,7381,4833,0763,5624,4896,1167,725
Operating Profit
Operating ProfitCr
2624223309001,2441,6832,1272,611
OPM
OPM%
14.819.618.222.625.927.325.825.3
Other Income
Other IncomeCr
1694-28319-14-86134111
Interest Expense
Interest ExpenseCr
179222205326329455512864
Depreciation
DepreciationCr
209192183256315397507680
PBT
PBTCr
-111103-866375867451,2421,178
Tax
TaxCr
25463290157212161262
PAT
PATCr
-13656-1175474295331,082917
Growth
PAT Growth%
141.5-308.3565.9-21.524.3102.9-15.3
NPM
NPM%
-7.72.6-6.513.88.98.613.18.9
EPS
EPS
-19.68.1-20.073.557.45.39.37.7

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
69696976767677236
Reserves
ReservesCr
1,1341,2011,0522,7323,1663,9385,7708,190
Current Liabilities
Current LiabilitiesCr
5456296921,7391,2141,6571,7953,362
Non Current Liabilities
Non Current LiabilitiesCr
1,7592,1732,1072,7083,1975,0756,27712,703
Total Liabilities
Total LiabilitiesCr
3,5184,1834,0317,3557,77710,81914,07224,865
Current Assets
Current AssetsCr
5866547161,3531,5882,0512,8554,109
Non Current Assets
Non Current AssetsCr
2,9323,5293,3146,0026,1898,76711,21720,756
Total Assets
Total AssetsCr
3,5184,1834,0317,3557,77710,81914,07224,865
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
69696976767677236
Reserves
ReservesCr
1,1341,2011,0522,7323,1663,9385,7708,190
Current Liabilities
Current LiabilitiesCr
5456296921,7391,2141,6571,7953,362
Non Current Liabilities
Non Current LiabilitiesCr
1,7592,1732,1072,7083,1975,0756,27712,703
Total Liabilities
Total LiabilitiesCr
3,5184,1834,0317,3557,77710,81914,07224,865
Current Assets
Current AssetsCr
5866547161,3531,5882,0512,8554,109
Non Current Assets
Non Current AssetsCr
2,9323,5293,3146,0026,1898,76711,21720,756
Total Assets
Total AssetsCr
3,5184,1834,0317,3557,77710,81914,07224,865

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2664314268051,1491,3891,5702,078
Investing Cash Flow
Investing Cash FlowCr
-124-333-188-1,711-994-870-2,658-7,037
Financing Cash Flow
Financing Cash FlowCr
-104-98-280941-144-2509044,954
Net Cash Flow
Net Cash FlowCr
380-423412268-70-4
Free Cash Flow
Free Cash FlowCr
792293346298281,3941,575
CFO To PAT
CFO To PAT%
-196.2764.6-362.9147.2267.9260.4145.1226.8
CFO To EBITDA
CFO To EBITDA%
101.7102.0129.089.492.482.573.879.6
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2664314268051,1491,3891,5702,078
Investing Cash Flow
Investing Cash FlowCr
-124-333-188-1,711-994-870-2,658-7,037
Financing Cash Flow
Financing Cash FlowCr
-104-98-280941-144-2509044,954
Net Cash Flow
Net Cash FlowCr
380-423412268-70-4
Free Cash Flow
Free Cash FlowCr
792293346298281,3941,575
CFO To PAT
CFO To PAT%
-196.2764.6-362.9147.2267.9260.4145.1226.8
CFO To EBITDA
CFO To EBITDA%
101.7102.0129.089.492.482.573.879.6

Ratios

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
98,759
Price To Earnings
Price To Earnings
105.3
Price To Sales
Price To Sales
9.6
Price To Book
Price To Book
6.0
EV To EBITDA
EV To EBITDA
42.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
70.472.373.250.753.775.573.473.373.3
OPM
OPM%
14.819.618.222.625.927.325.825.325.3
NPM
NPM%
-7.72.6-6.513.88.98.613.18.98.9
ROCE
ROCE%
2.410.94.419.916.913.114.39.69.6
ROE
ROE%
-11.34.4-10.519.513.213.318.510.910.9
ROA
ROA%
-3.91.4-2.97.45.54.97.73.73.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
98,759
Price To Earnings
Price To Earnings
105.3
Price To Sales
Price To Sales
9.6
Price To Book
Price To Book
6.0
EV To EBITDA
EV To EBITDA
42.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
70.472.373.250.753.775.573.473.373.3
OPM
OPM%
14.819.618.222.625.927.325.825.325.3
NPM
NPM%
-7.72.6-6.513.88.98.613.18.98.9
ROCE
ROCE%
2.410.94.419.916.913.114.39.69.6
ROE
ROE%
-11.34.4-10.519.513.213.318.510.910.9
ROA
ROA%
-3.91.4-2.97.45.54.97.73.73.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Manipal Health Enterprises Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/ja6oqx4yxtfxbcy6j95kphg9.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/94zr1i67749yzfihdz0tyyef.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/e2eo304v0hglsdv62q29wm28.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/o1iotddlo9z9tgatmsyu1sq6.pdf

Concall Transcript Summaries — Manipal Health Enterprises Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AMANIPALHOS/transcript-notes/202606/ja6oqx4yxtfxbcy6j95kphg9.pdf